☆ 4.7 Article

Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Non-Functioning Pancreatic Neuroendocrine Tumors

ANNALS OF SURGICAL ONCOLOGY (2023)

Related references

Note: Only part of the references are listed.

Review Endocrinology & Metabolism

Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis

V Andreasi et al.

Summary: This meta-analysis aimed to estimate the rate of disease recurrence and investigate risk factors for disease relapse in patients undergoing curative surgery for NF-PanNENs. The results showed a recurrence rate of approximately one out of five patients, with nodal involvement, tumor grade, microvascular, and perineural invasion identified as significant prognostic factors.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2022)

Add to Collection

Article Surgery

Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors

Alessandra Pulvirenti et al.

Summary: The developed nomogram accurately predicts the probability of recurrence-free survival at 5 years after curative resection for PanNETs, showing improved accuracy over current staging systems. Individual recurrence risk estimation can assist in developing personalized surveillance programs post-surgery.

ANNALS OF SURGERY (2021)

Add to Collection

Article Surgery

Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting

Stefano Partelli et al.

Summary: The study found that compared to ODP surgery, MIDP surgery had lower postoperative complications and shorter length of stay, but fewer lymph nodes examined. There was no significant difference in disease-free survival and overall survival between the two groups.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2021)

Add to Collection

Review Oncology

Systematic Review and Metaanalysis of Lymph Node Metastases of Resected Pancreatic Neuroendocrine Tumors

Masayuki Tanaka et al.

Summary: This study suggests that lymph node metastasis is not uncommon in small and well-differentiated PNETs, and it is associated with worse prognosis. Reevaluation of the watch-and-wait strategy for small NF-PNETs is recommended, with consideration of oncologic resection with lymphadenectomy. More prospective and controlled studies are needed in the future.

ANNALS OF SURGICAL ONCOLOGY (2021)

Add to Collection

Article Endocrinology & Metabolism

Prognostic Role of Examined and Positive Lymph Nodes after Distal Pancreatectomy for Non-Functioning Neuroendocrine Neoplasms

Giovanni Guarneri et al.

Summary: A minimal number of 12 nodes should be harvested in case of DP for NF-PanNET for an appropriate nodal staging. The number of positive lymph nodes is an independent predictor of DFS after DP for NF-PanNET, and the N0/N1/N2 nodal classification seems to be more relevant than the current N0/N+ staging.

NEUROENDOCRINOLOGY (2021)

Add to Collection

Article Oncology

c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation

Tsung-Ming Chang et al.

Summary: Pancreatic neuroendocrine tumor (pNET) is a type of pancreatic tumor with neuroendocrine differentiation. Early stage pNET can be treated with surgical resection for long-term survival, while pNET with metastasis has a poor prognosis. In this study, it was found that c-Myc overexpression is associated with lymph node metastasis in pNET xenograft mice. Combination therapy using an mTOR inhibitor and c-Myc inhibitor or VEGFC-neutralizing protein reduced lymph node metastasis in mice with c-Myc overexpression, indicating potential therapeutic targets for pNET.

CANCER SCIENCE (2021)

Add to Collection

Article Endocrinology & Metabolism

Meta-Analysis of Prognostic Factors for Recurrence of Resected Well-Differentiated Pancreatic Neuroendocrine Tumors

Yuanliang Li et al.

Summary: This study included 10 articles on prognostic factors for WDPNETs recurrence, and found that G2 grade, positive lymph nodes and surgical resection margin, vascular invasion, and perineural invasion may affect disease-free survival of WDPNETs, suggesting the need for closer postoperative follow-up and potential benefit from adjuvant therapy.

NEUROENDOCRINOLOGY (2021)

Add to Collection

Article Endocrinology & Metabolism

The Impact of 68Gallium DOTA PET/CT in Managing Patients With Sporadic and Familial Pancreatic Neuroendocrine Tumours

Daniel J. Cuthbertson et al.

Summary: This study evaluated the role of (68)Gallium (Ga-68)-DOTA PET/CT in managing patients with panNETs, showing that the imaging findings provided additional information in 54% of patients and influenced management in 39% of cases. The PET/CT scan more accurately stages and guides treatment in patients with sporadic/familial panNETs.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Article Surgery

Sporadic non-functioning pancreatic neuroendocrine tumours: multicentre analysis

C. Ricci et al.

Summary: This study evaluated outcomes after surgery for sporadic pancreatic neuroendocrine neoplasms (Pan-NENs), identifying 2019 WHO grade and ENETS TNM stage as important factors. Surgical approach may be without benefit for Pan-NECs, unnecessary for small G1 sporadic Pan-NENs, and insufficient for stage III-IV and G3 Pan-NENs.

BRITISH JOURNAL OF SURGERY (2021)

Add to Collection

Article Gastroenterology & Hepatology

The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors

James R. Howe et al.

PANCREAS (2020)

Add to Collection

Article Oncology

Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up y

M. Pavel et al.

ANNALS OF ONCOLOGY (2020)

Add to Collection

Article Surgery

Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors

Stefano Partelli et al.

SURGERY (2020)

Add to Collection

Article Oncology

Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group

Alexandra G. Lopez-Aguiar et al.

ANNALS OF SURGICAL ONCOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

The Number of Metastatic Lymph Nodes is a Useful Predictive Factor for Recurrence after Surgery for Nonmetastatic Nonfunctional Neuroendocrine Neoplasm of the Pancreas

G. Capretti et al.

GASTROENTEROLOGY RESEARCH AND PRACTICE (2019)

Add to Collection

Article Surgery

Evaluation of the Site and Frequency of Lymph Node Metastasis with Non-Functioning Pancreatic Neuroendocrine Tumor

Wataru Izumo et al.

EUROPEAN SURGICAL RESEARCH (2019)

Add to Collection

Article Endocrinology & Metabolism

Patterns of Recurrence after Resection for Pancreatic Neuroendocrine Tumors: Who, When, and Where?

Giovanni Marchegiani et al.

NEUROENDOCRINOLOGY (2019)

Add to Collection

Article Multidisciplinary Sciences

DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors

Mauro Cives et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Article Oncology

The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms

Stefano Partelli et al.

EJSO (2018)

Add to Collection

Article Endocrinology & Metabolism

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours

Stefano Partelli et al.

NEUROENDOCRINOLOGY (2017)

Add to Collection

Article Endocrinology & Metabolism

ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors

M. Falconi et al.

NEUROENDOCRINOLOGY (2016)

Add to Collection

Review Oncology

Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)

Franck Bonnetain et al.

EUROPEAN JOURNAL OF CANCER (2014)

Add to Collection

Article Surgery

Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: A consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)

Johanna A. M. G. Tol et al.

SURGERY (2014)

Add to Collection

Article Surgery

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies

Erik von Elm et al.

INTERNATIONAL JOURNAL OF SURGERY (2014)

Add to Collection

Article Surgery

Pattern and Clinical Predictors of Lymph Node Involvement in Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PanNETs)

Stefano Partelli et al.

JAMA SURGERY (2013)

Add to Collection

Article Surgery

Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor

Rossella Bettini et al.

SURGERY (2011)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

The Role of Ga-68-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on In-111-DTPA-Octreotide Scintigraphy

Rajaventhan Srirajaskanthan et al.

JOURNAL OF NUCLEAR MEDICINE (2010)

Add to Collection

Article Pathology

TNM staging of foregut (neuro)endocrine tumors:: a consensus proposal including a grading system

G. Rindi et al.

VIRCHOWS ARCHIV (2006)

Add to Collection

Article Surgery

Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey

D Dindo et al.

ANNALS OF SURGERY (2004)

Add to Collection

Article Biochemistry & Molecular Biology

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

SJ Mandriota et al.

EMBO JOURNAL (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.